Location History:
- Tucson, AZ (US) (2007 - 2008)
- Bengaluru, IN (2013 - 2015)
Company Filing History:
6 out of 972 
3 out of 3 
1 out of 52 Years Active: 2007-2015
Title: Sridevi Bashyam: Innovator in Protein Kinase Inhibitors
Introduction
Sridevi Bashyam is a notable inventor based in Tucson, Arizona, recognized for her contributions to the field of medicinal chemistry. She holds a total of six patents, primarily focused on the development of protein kinase inhibitors that have significant implications in treating various diseases, including cancer.
Latest Patents
Among her latest patents, Sridevi has developed compounds that serve as protein kinase inhibitors. These compounds are designed to target protein kinase-mediated diseases and conditions, such as cancer. The patents disclose structures that include stereoisomers, prodrugs, and pharmaceutically acceptable salts. The compounds are characterized by specific ring moieties and substituents, which are defined in the patent documentation. Additionally, she has patented substituted tricyclic compounds that also function as protein kinase inhibitors, further expanding the potential therapeutic applications of her inventions.
Career Highlights
Sridevi Bashyam has had a distinguished career, working with prominent institutions such as the University of Arizona and Montigen Pharmaceuticals, Inc. Her work has significantly advanced the understanding and treatment of diseases related to protein kinases.
Collaborations
Throughout her career, Sridevi has collaborated with esteemed colleagues, including Laurence H. Hurley and Daruka Mahadevan. These collaborations have enriched her research and contributed to the success of her innovative projects.
Conclusion
Sridevi Bashyam's work in the field of protein kinase inhibitors showcases her dedication to advancing medical science. Her patents reflect a commitment to developing effective treatments for serious health conditions, particularly cancer. Her contributions continue to impact the field positively.